Paul Negulescu
scientistMale0.0Global Dominance: 0.00%
Paul Negulescu is a senior vice-president at Vertex Pharmaceuticals, playing a crucial role in the drug development of CFTR modulators for cystic fibrosis, significantly improving patient outcomes.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Paul Negulescu received international honors for his research on cystic fibrosis.
Ontario woman who fought for cystic fibrosis drug recognized for increasing accessThe Globe and Mail·
Canada· 2025-11-28
Canada· 2025-11-28
Paul Negulescu was a co-author of a constitutional law book during the dictatorship and is discussed in the context of legal exceptions.
Cine are dreptate în disputa Nicușor Dan vs CCR. Expert: „Să bagatelizezi un principiu liberal atât de important e greu de calificat”Adevărul·
Romania· 2025-07-20
Romania· 2025-07-20
Paul Negulescu led pioneering drug development for cystic fibrosis therapies.
In a time of despair for U.S. scientists, Gairdner Award winners shine brighter than usualThe Globe and Mail·Canada· 2025-04-11
Canada· 2025-04-11
